Biosino Bio-Technology and Science Incorporation (stock code: 08247) released its monthly return on movements in securities for 28 February 2026. The total authorized share capital stood at RMB 144.71 million, comprising 64.29 million H shares and 80.42 million domestic shares. According to the announcement, there were no changes to the company’s issued shares or treasury shares during the month.

The 64.29 million issued H shares continued to meet the minimum public float requirement. The company also confirmed there were no additional arrangements, warrants, or convertibles outstanding that might further affect its share capital. All data was sourced solely from the official announcement without alteration.